United States on Food and Drugs Law

Lowering Drug Prices By Once Again Putting Americans First (Trump EO Tracker)

This order makes it the policy of the United States that Federal health care programs, intellectual property protections, and safety regulations are optimized to provide access to prescription drugs...

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Post‑Chevron Spotlight: Federal Court Nixes FDA Rule Reclassifying Laboratory Services As Medical Devices

In another rebuke to federal regulatory overreach, the U.S. District Court for the Eastern District of Texas ("District Court") has vacated the Food and Drug Administration's ("FDA") 2024 final rule...

United States Healthcare

PR

Proskauer Rose LLP

EUON Publishes Nanopinion On Enhancing The Regulatory Application Of NAMs To Assess Nanomaterial Risks In The Food And Feed Sector

The authors explain how the NAMs4NANO project, funded by EFSA, enhances the regulatory application of NAMs for assessing nanomaterial risks in the food and feed sector.

United States Healthcare

BC

Bergeson & Campbell

Trump Administration Takes Next Steps Toward Pharmaceutical Tariffs

On April 14, 2025, the U.S. Department of Commerce released a Notice announcing that it was conducting a Section 232 investigation into pharmaceuticals and related products...

United States Healthcare

AP

Arnold & Porter

Life Sciences Companies Must Navigate The DOJ Data Rule

Worldwide Privacy

GP

Goodwin Procter LLP

FDA To Phase Out Animal Testing For Monoclonal Antibodies And Other Drugs

United States Healthcare

GP

Goodwin Procter LLP

FDA Announces Plan To Phase Out Animal Testing Requirement

United States Healthcare

HK

Holland & Knight

Regulation, Enforcement, And Associated Challenges Of The ENDS Industry: Part II

United States IP

M

Mintz

Commerce Opens Short Comment Window In Section 232 Pharmaceuticals Investigation

United States Healthcare

CL

Cassidy Levy Kent

Supreme Court Gives Centre Three Months To Finalize Nutrition Labels On Packaged Foods

United States Media & IT

GA

Global Advertising Lawyers Alliance (GALA)

Axinn Associates At The Antitrust Spring Meeting: Pharma Under The Antitrust Microscope

United States Anti-trust

AV

Axinn Veltrop & Harkrider

Federal 340B Drug Pricing Program Failing Patients, Increasing Drug Costs

United States Employment

HB

Hall Benefits Law

2025 Food And Beverage Industry: Top Trends And Tariff Impacts

United States Healthcare

ML

Marcum

HHS Restructuring And Workforce Reductions – Key Implications For The Health Care Industry

United States Healthcare

M

Mintz

DOJ Memo Previews Immigration Enforcement Actions

United States Immigration

Gs

Green and Spiegel

President Trump Restores Section 232 Tariffs

United States International

BG

Braumiller Law Group, PLLC

Should We Expect More Tariffs In The Future? Understanding Trump's America First Trade Policy

United States International

BG

Braumiller Law Group, PLLC

The External Revenue Service: A Bureaucratic Overreach Or Necessary Reform?

United States International

BG

Braumiller Law Group, PLLC

[PODCAST] JAMS Neutrals Discuss How Austin's Growth Is Shaping Dispute Resolution

United States Litigation

J

JAMS

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More